AT-Patch (ATP-C130/ATP-C70) vs CT VScore+
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if you require continuous, long-term cardiac monitoring for up to 14 days to detect intermittent arrhythmias or evaluate symptoms that occur sporadically. Its wearable, shower-proof design and integrated AI analysis are ideal for patients needing extended, comfortable ECG recording in their daily environment.
View AT-Patch (ATP-C130/ATP-C70) →Choose CT VScore+ if…
Choose CT VScore+ if you need an automated, non-invasive assessment of coronary artery calcification from ECG-gated, non-contrast cardiac CT images for cardiovascular risk stratification. This tool is best suited for quickly obtaining accurate Agatston and volume scores to inform patient management and risk assessment based on existing calcification.
View CT VScore+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | CT VScore+ |
|---|---|---|
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AT-Patch (ATP-C130/ATP-C70)AT-Patch offers superior usability from a patient perspective due to its wearable, compact, and shower-proof design, allowing for normal daily activities during up to 14 days of continuous monitoring without intervention. The accompanying smartphone app further enhances patient engagement by enabling live ECG viewing and symptom recording. While CT VScore+ improves clinical workflow for radiologists, AT-Patch's direct patient-centric usability for extended periods gives it an edge.
Clinical Value
AT-Patch (ATP-C130/ATP-C70)Both tools offer significant clinical value in their respective domains. However, AT-Patch's ability to provide long-term, continuous ECG monitoring for up to 14 days, coupled with its AI-powered arrhythmia detection, has demonstrated superior sensitivity in detecting intermittent and often asymptomatic arrhythmias like paroxysmal atrial fibrillation compared to traditional methods. This extended monitoring and high detection rate can lead to earlier diagnosis and intervention for potentially life-threatening cardiac conditions.
Pricing & Value
TieNeither tool provides public pricing information, requiring direct contact with the respective companies for quotes. This lack of transparency makes it impossible to conduct a head-to-head comparison on pricing or to assess their relative value proposition.
Enterprise Readiness
CT VScore+CT VScore+ explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, which are critical for enterprise adoption in healthcare. It also runs on the Vitrea platform, designed for enterprise scalability. While AT-Patch is FDA-cleared and likely HIPAA compliant, the explicit mention of BAA and its integration with an established enterprise platform gives Tool B a slight advantage in terms of documented enterprise readiness.
Innovation
AT-Patch (ATP-C130/ATP-C70)AT-Patch demonstrates greater innovation by combining a patient-friendly, long-duration wearable device with integrated AI for continuous, high-accuracy ECG monitoring in daily life. Its design addresses patient comfort and adherence for extended periods, a significant advancement in remote cardiac diagnostics. While CT VScore+ innovates in automating radiology workflows with AI, AT-Patch's blend of hardware and software for continuous, unobtrusive patient data acquisition is arguably more groundbreaking in its approach to healthcare delivery.
Support & Docs
TieBoth companies appear to offer standard support and documentation. AT-Patch provides user manuals for its device and app online, while Canon Medical Informatics lists customer support and education services for CT VScore+. Without more specific details on the breadth, accessibility, or quality of these offerings, it is difficult to definitively declare a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | CT VScore+ |
|---|---|---|
| Name | AT-Patch (ATP-C130/ATP-C70) | CT VScore+ |
| Company | ATsens Co. | Canon Medical Informatics |
| Description | FDA-cleared wearable ECG monitor offering up to 14 days of continuous cardiac monitoring with high accuracy, a shower-proof design, and integrated AI-powered analysis software for enhanced arrhythmia detection. | AI-powered software application that automates cardiac calcium scoring from ECG-gated, non-contrast cardiac CT images, providing Agatston and volume scores for coronary risk assessment. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Radiology |
| Key Features | Up to 14 days of continuous ECG monitoring (ATP-C130), High-performance sensor chip for accurate ECG signal acquisition, Short-length electrode to minimize motion artifact noise, Shower-proof design (IP57 for ATP-C130, IP44 for ATP-C70), No charging or electrode replacement required during monitoring, Compact and lightweight (13g) for patient comfort, AT-Note smartphone app for live ECG viewing and symptom recording, AT-Report software with AI/machine learning algorithms for ECG analysis | Automated cardiac calcium scoring, Removes manual data entry from reporting, Generates Agatston and volume calcium scores, Highlights segmented calcium on CT images, Runs on Vitrea platform, Non-invasive evaluation of coronary artery calcified lesions, Utilizes ECG-gated, non-contrast cardiac CT images, Provides calcium percentile comparison to reference data (MESA, Hoff-Kondos) |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and CT VScore+.